HK1204016A1 - Methods and kits for detecting subjects at risk of having cancer - Google Patents
Methods and kits for detecting subjects at risk of having cancerInfo
- Publication number
- HK1204016A1 HK1204016A1 HK15104496.4A HK15104496A HK1204016A1 HK 1204016 A1 HK1204016 A1 HK 1204016A1 HK 15104496 A HK15104496 A HK 15104496A HK 1204016 A1 HK1204016 A1 HK 1204016A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kits
- cancer
- risk
- methods
- detecting subjects
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161577441P | 2011-12-19 | 2011-12-19 | |
PCT/US2012/068148 WO2013095941A1 (en) | 2011-12-19 | 2012-12-06 | Methods and kits for detecting subjects at risk of having cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204016A1 true HK1204016A1 (en) | 2015-11-06 |
Family
ID=48669353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104496.4A HK1204016A1 (en) | 2011-12-19 | 2015-05-12 | Methods and kits for detecting subjects at risk of having cancer |
Country Status (6)
Country | Link |
---|---|
US (2) | US9850541B2 (xx) |
EP (1) | EP2800820B1 (xx) |
JP (2) | JP6408380B2 (xx) |
CA (1) | CA2859021A1 (xx) |
HK (1) | HK1204016A1 (xx) |
WO (1) | WO2013095941A1 (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9447471B2 (en) * | 2011-12-29 | 2016-09-20 | Quest Diagnostics Investments Incorporated | Microrna profiling for diagnosis of dysplastic nevi and melanoma |
US9377091B2 (en) * | 2013-06-21 | 2016-06-28 | Eaton Corporation | Shaft assemblies suitable for circuit breakers and related circuit breakers |
EP2829613A1 (en) * | 2013-07-26 | 2015-01-28 | Istituto Nazionale Di Genetica Molecolare-INGM | Biomarkers of liver diseases and uses thereof |
WO2015073531A1 (en) * | 2013-11-13 | 2015-05-21 | The Texas A & M University System | Micro-rnas that modulate lymphangiogenesis and inflammatory pathways in lymphatic vessel cells |
JP6611411B2 (ja) * | 2013-12-05 | 2019-11-27 | 東レ株式会社 | 膵臓がんの検出キット及び検出方法 |
CN106459961B (zh) * | 2014-05-30 | 2020-08-25 | 东丽株式会社 | 胰腺癌的检测试剂盒或装置以及检测方法 |
EP3971299A3 (en) | 2014-06-13 | 2022-06-29 | Toray Industries, Inc. | Colorectal cancer detection kit or device, and detection method |
JP5852759B1 (ja) * | 2015-04-01 | 2016-02-03 | 株式会社キュービクス | 遺伝子発現解析による膵臓癌の検出 |
JP5970123B1 (ja) * | 2015-12-04 | 2016-08-17 | 株式会社キュービクス | 遺伝子発現解析による膵臓癌の検出 |
EP3988668A3 (en) | 2016-03-31 | 2022-06-29 | Toray Industries, Inc. | Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor |
JP2020513574A (ja) * | 2016-11-24 | 2020-05-14 | ヒュベット バイオ, インコーポレイテッドHuvet Bio, Inc. | 疾患の診断用組成物 |
EP3725881A1 (en) * | 2017-12-13 | 2020-10-21 | Hiroshima University | Method for aiding detection of pancreatic cancer |
EP3725897A4 (en) | 2017-12-13 | 2022-01-05 | Hiroshima University | HEAD AND NECK CANCER CANCER ASSISTANCE PROCESS |
WO2021118349A1 (en) * | 2019-12-10 | 2021-06-17 | Prinses Máxima Centrum Voor Kinderoncologie B.V. | Methods of typing germ cell tumors |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5215882A (en) | 1989-11-30 | 1993-06-01 | Ortho Diagnostic Systems, Inc. | Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5707807A (en) | 1995-03-28 | 1998-01-13 | Research Development Corporation Of Japan | Molecular indexing for expressed gene analysis |
US5958342A (en) | 1996-05-17 | 1999-09-28 | Incyte Pharmaceuticals, Inc. | Jet droplet device |
US6060240A (en) | 1996-12-13 | 2000-05-09 | Arcaris, Inc. | Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom |
US6090556A (en) | 1997-04-07 | 2000-07-18 | Japan Science & Technology Corporation | Method for quantitatively determining the expression of a gene |
US5994076A (en) | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
US6048695A (en) | 1998-05-04 | 2000-04-11 | Baylor College Of Medicine | Chemically modified nucleic acids and methods for coupling nucleic acids to solid support |
US6087112A (en) | 1998-12-30 | 2000-07-11 | Oligos Etc. Inc. | Arrays with modified oligonucleotide and polynucleotide compositions |
DE60332948D1 (de) | 2002-07-19 | 2010-07-22 | Althea Technologies Inc | Strategien zur genexpressionsanalyse |
US20060094025A1 (en) * | 2004-11-02 | 2006-05-04 | Getts Robert C | Methods for detection of microrna molecules |
EP2487260B1 (en) * | 2006-01-05 | 2015-07-08 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis and treatment of solid cancers |
EP2522747A1 (en) | 2006-03-02 | 2012-11-14 | The Ohio State University | MicroRNA expression profile associated with pancreatic cancer |
WO2008124777A1 (en) * | 2007-04-10 | 2008-10-16 | National Taiwan University | Predicting post-treatment survival in cancer patients with micrornas |
WO2008154333A2 (en) * | 2007-06-08 | 2008-12-18 | Asuragen, Inc. | Mir-34 regulated genes and pathways as targets for therapeutic intervention |
EP2340310B1 (en) * | 2008-09-22 | 2015-06-03 | RXi Pharmaceuticals Corporation | Reduced size self-delivering rnai compounds |
WO2010048317A2 (en) | 2008-10-21 | 2010-04-29 | The Board Of Regents Of The University Of Texas System | Micro-rnas as markers for tumor progression |
US8735074B2 (en) | 2009-08-28 | 2014-05-27 | Asuragen, Inc. | MiRNA biomarkers of lung disease |
EP3150721B1 (en) * | 2009-12-24 | 2019-05-15 | Micromedmark Biotech Co., Ltd | Pancreatic cancer markers and detecting methods |
US20130065778A1 (en) * | 2010-01-26 | 2013-03-14 | Yale University | MicroRNA Signatures Predicting Responsiveness To Anti-HER2 Therapy |
US20110223607A1 (en) | 2010-03-12 | 2011-09-15 | Quest Diagnostics Investments Incorporated | Circulating microrna as a marker for hepatocellular carcinoma |
-
2012
- 2012-12-06 US US14/364,472 patent/US9850541B2/en active Active
- 2012-12-06 JP JP2014549087A patent/JP6408380B2/ja not_active Expired - Fee Related
- 2012-12-06 CA CA2859021A patent/CA2859021A1/en not_active Abandoned
- 2012-12-06 EP EP12859233.4A patent/EP2800820B1/en active Active
- 2012-12-06 WO PCT/US2012/068148 patent/WO2013095941A1/en active Application Filing
-
2015
- 2015-05-12 HK HK15104496.4A patent/HK1204016A1/xx unknown
-
2017
- 2017-12-22 US US15/852,954 patent/US20180105888A1/en not_active Abandoned
-
2018
- 2018-09-20 JP JP2018176466A patent/JP6720260B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2015502176A (ja) | 2015-01-22 |
US9850541B2 (en) | 2017-12-26 |
JP2019030305A (ja) | 2019-02-28 |
WO2013095941A1 (en) | 2013-06-27 |
US20150011410A1 (en) | 2015-01-08 |
EP2800820A4 (en) | 2016-03-30 |
CA2859021A1 (en) | 2013-06-27 |
US20180105888A1 (en) | 2018-04-19 |
EP2800820B1 (en) | 2020-04-08 |
JP6720260B2 (ja) | 2020-07-08 |
EP2800820A1 (en) | 2014-11-12 |
JP6408380B2 (ja) | 2018-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1204016A1 (en) | Methods and kits for detecting subjects at risk of having cancer | |
HK1206065A1 (en) | Compositions and methods for analyte detection | |
HK1212932A1 (zh) | 用於檢測和獲取生物標誌物的方法和裝置 | |
HK1209793A1 (en) | Methods of detecting diseases or conditions | |
EP2847593A4 (en) | METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER | |
GB2507231B (en) | Methods for Detection of Cytosine Modification | |
EP2670866A4 (en) | BIOMARKERS AND METHODS OF USE | |
EP2790579A4 (en) | METHOD AND APPARATUS FOR DETECTING THE APPEARANCE OF HYPOGLYCEMIA | |
HK1200037A1 (en) | Non-invasive methods of detecting target molecules | |
HK1198705A1 (en) | Apparatus and methods for detecting analytes | |
EP2675485A4 (en) | ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER | |
HK1259001A1 (zh) | 癌症的預後和診斷方法 | |
EP2668295A4 (en) | METHODS OF DETECTING LUNG CANCER | |
GB201120965D0 (en) | System and method for detection of analytes | |
GB2533873B (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer | |
IL232493A0 (en) | A method for quantifying cancer treatment | |
IL230693A0 (en) | Use of the i-3859 antibody for the detection and diagnosis of cancer | |
IL236436A0 (en) | Kits and methods for the detection of cyanide | |
HK1205558A1 (en) | Methods and biomarkers for detection and prognosis of cervical cancer | |
SG11201402115TA (en) | Methods for diagnosis and/or prognosis of gynecological cancer | |
EP2904393A4 (en) | METHOD AND KIT FOR MEASURING AN ANALYTE UNDER ACIDIC CONDITIONS | |
GB201215924D0 (en) | Kit and method for quantitative detection of steroids | |
EP2894474A4 (en) | METHOD AND KIT FOR DETECTION OF RENAL CANCER BIOMARKERS IN THE BLOOD | |
EP2786150A4 (en) | DETECTION OF MULTIPLE ANALYTES | |
EP2699699A4 (en) | METHOD FOR THE DIAGNOSIS OF CANCER |